Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.

Uchida K, Nakajima H, Miyazaki T, Tsuchida T, Hirai T, Sugita D, Watanabe S, Takeura N, Yoshida A, Okazawa H, Baba H.

Asian Spine J. 2013 Jun;7(2):96-103. doi: 10.4184/asj.2013.7.2.96. Epub 2013 May 22.

2.

(18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.

Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G.

Hell J Nucl Med. 2011 Sep-Dec;14(3):311-2.

PMID:
22087457
3.

Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?

Sahin E, Zincirkeser S, Akcan AB, Elboga U.

J BUON. 2014 Jan-Mar;19(1):291-6.

PMID:
24659678
4.

Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.

Ak I, Sivrikoz MC, Entok E, Vardareli E.

Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16.

PMID:
20015657
5.
6.

Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.

Lee JW, Lee SM, Lee HS, Kim YH, Bae WK.

Ann Nucl Med. 2012 Oct;26(8):627-33. doi: 10.1007/s12149-012-0622-3. Epub 2012 Jun 24.

PMID:
22729551
7.

Usefulness of (18)F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases.

Yoon SH, Kim KS, Kang SY, Song HS, Jo KS, Choi BH, Lee SJ, Yoon JK, An YS.

Nucl Med Mol Imaging. 2013 Mar;47(1):27-35. doi: 10.1007/s13139-012-0178-0. Epub 2012 Oct 27.

8.

Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.

Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA.

Acta Radiol. 2016 Jan;57(1):58-65. doi: 10.1177/0284185114564438. Epub 2014 Dec 22.

PMID:
25533313
9.

Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.

Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF.

Anticancer Res. 2000 May-Jun;20(3B):2189-92.

PMID:
10928175
10.

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.

J Nucl Med. 2008 Feb;49(2):195-200. doi: 10.2967/jnumed.107.045641. Epub 2008 Jan 16.

12.

Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.

Ozülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T.

Nucl Med Commun. 2010 Jun;31(6):597-603. doi: 10.1097/MNM.0b013e328338e909.

PMID:
20224457
13.
14.

Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.

Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.

J Nucl Med. 2015 Dec;56(12):1862-8. doi: 10.2967/jnumed.115.162610. Epub 2015 Sep 24.

15.
16.

Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.

Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, Nakamoto Y, Higashi T, Saga T, Konishi J.

Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):491-8. Epub 2003 Dec 10.

PMID:
14666387
17.
18.

Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.

Iagaru A, Mittra E, Dick DW, Gambhir SS.

Mol Imaging Biol. 2012 Apr;14(2):252-9. doi: 10.1007/s11307-011-0486-2.

PMID:
21479710
19.
20.

Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.

Ito S, Kato K, Ikeda M, Iwano S, Makino N, Tadokoro M, Abe S, Nakano S, Nishino M, Ishigaki T, Naganawa S.

J Nucl Med. 2007 Jun;48(6):889-95. Epub 2007 May 15.

Supplemental Content

Support Center